| Literature DB >> 35341146 |
Ping-Hsun Lu1,2, Yu-Yang Chen3, Fu-Ming Tsai4, Yuan-Ling Liao1, Hui-Fen Huang1,2, Wei-Hsuan Yu3, Chan-Yen Kuo4.
Abstract
Obesity is a prevalent metabolic disease that increases the risk of other diseases, such as hypertension, diabetes, hyperlipidemia, cardiovascular disease, and certain cancers. A meta-analysis of 11 randomized sham-controlled trials indicates that acupuncture had adjuvant benefits in improving simple obesity, and previous studies have reported that acupoint combinations were more useful than single-acupoint therapy. The Apriori algorithm, a data mining-based analysis that finds potential correlations in datasets, is broadly applied in medicine and business. This study, based on the Apriori algorithm-based association rule analysis, found the association rules of acupoints among 11 randomized controlled trials (RCTs). There were 23 acupoints extracted from 11 RCTs. We used Python to calculate the association between acupoints and disease. We found the top 10 frequency acupoints were Extra12, TF4, LI4, LI11, ST25, ST36, ST44, CO4, CO18, and CO1. We investigated the 1118 association rule and found that {LI4, ST36} ≥ {ST44}, {LI4, ST44} ≥ {ST36}, and {ST36, ST44} ≥ {LI4} were the most associated rules in the data. Acupoints, including LI4, ST36, and ST44, are the core acupoint combinations in the treatment of simple obesity.Entities:
Year: 2022 PMID: 35341146 PMCID: PMC8947926 DOI: 10.1155/2022/7252213
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Summary of selected studies.
| Study (year) | Study design | Inclusion criteria (kg/m2) | Acupoints | Jadad score |
|---|---|---|---|---|
| Tuğrul Cabioğlu and Ergene (2005) [ | RCT | BMI > 30 | Extra12, TF4, LI 4, LI11, ST25, ST36, ST44 | 5 |
| Cabioğlu and Ergene (2006) [ | RCT | BMI > 30 | Extra12, TF4, LI 4, LI11, ST25, ST36, ST44 | 5 |
| Cabioğlu et al. (2008) [ | RCT | BMI > 30 | Extra12, TF4, LI 4, LI11, ST25, ST36, ST44 | 5 |
| Hsu et al. (2009) [ | RCT | BMI > 27 | TF4, CO4, Extra12, CO18 | 6 |
| Abdi et al. (2012) [ | RCT | BMI > 30 | TF4, CO4, Extra12, CO1, HX1, CO17 | 5 |
| Güçel et al. (2012) [ | RCT | BMI > 30 | LI4, HT7, ST36, ST44, SP6 | 6 |
| Lien et al. (2012) [ | RCT | BMI > 27 | TF4, CO4, Extra12, CO18 | 6 |
| Darbandi et al. (2013) [ | RCT | BMI > 25 | ST25, GB28, RN12, RN9, RN4, SP6 | 5 |
| Yeo et al. (2014) [ | RCT | BMI > 23 | TF4, CO4, CO13, Extra12, CO18 | 5 |
| Darbandi et al. (2014) [ | RCT | BMI > 30–40 | ST25, GB28, REN12, REN9, REN4, SP6, TF4, CO4, Extra12, CO1, HX1, CO17 | 5 |
| Fogarty et al. (2015) [ | RCT | BMI > 25 | LI4, LI11, ST36, ST44, LR3 | 5 |
RCT = randomized controlled trial; BMI = body mass index.
Figure 1Frequency distribution of acupoints used in the 11 RCTs included in the meta-analysis.
Figure 2Scatter plot for the 1118 association rules obtained in the 11 RCTs included in the meta-analysis.
Apriori algorithm-based association rules for acupoints used for obesity treatment.
| No. | Association rules | Support | Confidence | Expected confidence | Lift |
|---|---|---|---|---|---|
| 1 | {Extra12} ≥ {TF4} | 0.727272 | 1.000000 | 0.727272 | 1.37500 |
| 2 | {TF4} ≥ {Extra12} | 0.727272 | 1.000000 | 0.727272 | 1.37500 |
| 3 | {CO4} ≥ {Extra12} | 0.454545 | 1.000000 | 0.727272 | 1.37500 |
| 4 | {CO4} ≥ {TF4} | 0.454545 | 1.000000 | 0.727272 | 1.37500 |
| 5 | {LI4} ≥ {ST36} | 0.454545 | 1.000000 | 0.454545 | 2.20000 |
| 6 | {ST36} ≥ {LI4} | 0.454545 | 1.000000 | 0.454545 | 2.20000 |
| 7 | {LI4} ≥ {ST44} | 0.454545 | 1.000000 | 0.454545 | 2.20000 |
| 8 | {ST44} ≥ {LI4} | 0.454545 | 1.000000 | 0.454545 | 2.20000 |
| 9 | {ST36} ≥ {ST44} | 0.454545 | 1.000000 | 0.454545 | 2.20000 |
| 10 | {ST44} ≥ {ST36} | 0.454545 | 1.000000 | 0.454545 | 2.20000 |
| 11 | {ST25} ≥ {Extra12} | 0.363636 | 0.800000 | 0.909090 | 1.10000 |
| 12 | {ST25} ≥ {TF4} | 0.363636 | 0.800000 | 0.909090 | 1.10000 |
| 13 | {LI4} ≥ {LI11} | 0.363636 | 0.800000 | 0.454545 | 2.20000 |
| 14 | {LI11} ≥ {LI4} | 0.363636 | 1.000000 | 0.454545 | 2.20000 |
| 15 | {LI11} ≥ {ST36} | 0.363636 | 1.000000 | 0.454545 | 2.20000 |
| 16 | {ST36} ≥ {LI11} | 0.363636 | 0.800000 | 0.454545 | 2.20000 |
| 17 | {LI11} ≥ {ST44} | 0.363636 | 1.000000 | 0.454545 | 2.20000 |
| 18 | {ST44} ≥ {ST11} | 0.363636 | 0.800000 | 0.454545 | 2.20000 |
Figure 3Grouping matrix for the 10 association rules obtained in the 11 RCTs included in the meta-analysis.
Figure 4Location of core acupoints in the treatment of patients with obesity.
Potential efficacy of the core acupoints for obesity treatment.
| Acupoint | Chinese name | English name | Primary meridians | Efficacy |
|---|---|---|---|---|
| LI4 [ | Ho-Ku | Connecting valleys | Large intestine | To increase the levels of serum insulin and C peptide |
| ST36 [ | Tsu-San-Li | Walking three miles | Stomach | To increase the levels of serum insulin and C peptide; to remodel WAT to BAT |
| ST44 [ | Nei-T'ing | Inner court | Stomach | To increase the levels of serum insulin and C peptide; to remodel WAT to BAT |
WAT: white adipose tissue; BAT: brown adipose tissue.